A subset of FreeStyle Libre 3 sensors from Abbott may produce inaccurate glucose readers, the company recently announced.
The Illinois-based medical technology firm issued a voluntary medical device correction for a limited number of FreeStyle Libre3 sensors distributed in the US during the first half of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?